Arvinas Inc (ARVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARVN | AMGN | VRTX | BMY | GILD |
| Company | Arvinas Inc | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 25.04 | 275.01 | 458.06 | 58.84 | 93.50 |
| High | 26.42 | 275.36 | 465.90 | 59.53 | 94.22 |
| Low | 24.76 | 271.48 | 456.86 | 58.69 | 92.03 |
| Last | 25.92 | 272.58 | 462.10 | 59.38 | 92.13 |
| Change | +1.18 | -1.75 | +2.18 | +0.54 | -1.26 |
| % Change | +4.77% | -0.64% | +0.47% | +0.92% | -1.35% |
| Volume | 495,000 | 3,970,300 | 1,115,300 | 7,277,000 | 4,470,700 |
| 20-Day Average Volume | 678,660 | 4,673,665 | 1,376,875 | 11,103,835 | 7,318,660 |
| Previous Close | 24.74 | 274.33 | 459.92 | 58.84 | 93.39 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 25.05 | 288.82 | 469.52 | 58.37 | 91.82 |
| 20-Day Raw Stochastic | 63.08% | 20.98% | 22.84% | 76.09% | 47.19% |
| 20-Day Relative Strength | 51.15% | 31.35% | 46.49% | 60.90% | 55.67% |
| Weighted Alpha | -29.17 | -7.29 | +22.48 | +27.82 | +25.80 |
| Today's Opinion | 56% Sell | 72% Sell | 24% Sell | 100% Buy | 100% Buy |
| Previous Opinion | 100% Sell | 72% Sell | 24% Sell | 100% Buy | 100% Buy |
| Last Month's Opinion | 8% Sell | 24% Buy | 88% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.99% since 11/29/24 | -3.64% since 11/29/24 | -1.29% since 11/29/24 | +0.27% since 11/29/24 | -0.49% since 11/29/24 |
| Low | 23.82 on 12/04/24 | 271.48 on 12/06/24 | 450.00 on 12/04/24 | 57.59 on 12/04/24 | 89.86 on 12/04/24 |
| High | 26.94 on 12/02/24 | 282.39 on 12/02/24 | 468.51 on 12/03/24 | 60.09 on 12/03/24 | 94.39 on 12/03/24 |
| 1-Month | |||||
| %Chg | -7.40% since 11/06/24 | -15.29% since 11/06/24 | -6.39% since 11/06/24 | +7.42% since 11/06/24 | +0.48% since 11/06/24 |
| Low | 21.17 on 11/20/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 53.97 on 11/08/24 | 86.08 on 11/19/24 |
| High | 28.75 on 11/07/24 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +6.23% since 09/06/24 | -14.97% since 09/06/24 | -1.26% since 09/06/24 | +21.93% since 09/06/24 | +17.04% since 09/06/24 |
| Low | 21.17 on 11/20/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 47.55 on 09/09/24 | 78.36 on 09/09/24 |
| High | 29.61 on 10/30/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -6.43% since 06/06/24 | -10.83% since 06/06/24 | -4.83% since 06/06/24 | +45.25% since 06/06/24 | +44.29% since 06/06/24 |
| Low | 21.17 on 11/20/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 39.35 on 07/05/24 | 62.69 on 06/18/24 |
| High | 34.11 on 07/16/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,781,041 | 146,520,736 | 119,004,152 | 120,433,152 | 114,818,480 |
| Shares Outstanding, K | 68,713 | 537,533 | 257,529 | 2,028,177 | 1,246,266 |
| Annual Sales | 78,500,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -367,300,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 102,400,000 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | -49,200,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 1.82 | 0.55 | 0.36 | 0.45 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.68 on 10/30/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 10/30/24 | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 10/04/24 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.27 | 0.00 | 50.29 | 21.08 |